Diese Seite wird euch auf bevorstehende Veranstaltungen und andere wichtige Informationen aufmerksam machen.

This page will keep you informed about upcoming events and other important information.

For images, please click on them to increase their sizes.

Basel - Toyama Online Conference 2026

Basel_Toyama 2026
  • A virtual platform for Basel–Toyama cultural and scientific collaboration.
  • For affiliated PhDs, Postdocs Supervisors, Scientists, and Colleagues
  • Possibility to earn 1 credit point for PhD students

PhD Summer School 2026

PhD Summer School 2026
  • Für PhDs im PhD-Programm für Pharmazeutische Wissenschaften und affiliierte PhDs
  • For PhDs in the PhD Program in Pharmaceutical Sciences and affiliated PhDs
  • Kick-off Meeting for Registered Participants (08 June 2026, 14:30)

Upcoming Public PhD Defenses

Who:Solenn Fabien
Research Group:Clinical Pharmacy & Epidemiology
Date and time:                26.05.2026, at 10.30 h 
Room:                              Hörsaal 2, PhZ
Teams:        https://teams.microsoft.com/meet/28810240526389?p=7BBhvlUIC6jHNQBiMe
Title of the talk:                                      Innovative Approaches to Heart Failure Research: Real-World Evidence and Digital Health Technologies to Optimize Disease Monitoring and Management
List of publications:

1. Fabien S et al. Smartwatches in the assessment of heart failure patients in epidemiology and pathophysiology studies: A scoping review. ESC Heart Fail. 2025 Jun;12(3):1727-1738. doi: 10.1002/ehf2.15226. Epub 2025 Feb 4. PMID: 39905203; PMCID: PMC12055391.

2. Greene SJ et al. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. J Card Fail. 2025 Jun;31(6):881-891. doi: 10.1016/j.cardfail.2024.08.048. Epub 2024 Sep 12. PMID: 39277029.

3. Greene SJ et al. Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry. Eur J Heart Fail. 2025 Nov;27(11):2410-2421. doi: 10.1002/ejhf.3800. Epub 2025 Aug 11. PMID: 40788620; PMCID: PMC12765463.

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
Who:Boris Ševarika 
Research Group:Pharmaceutical Technology Group / Nanopharmaceutical and Regulatory Science Group
Date and time:                28.05.2026 at 16:00h
Room:                              Biozentrum U1.191
Online Meeting:        meet.google.com/tab-jmuv-omn
Title of the talk:                                      

Development of Nanoparticle-Based Enzyme Replacement Therapy 

Platform for Lysosomal Delivery of Therapeutic Enzymes

List of publications:

Sevarika, B.; Couvidou, A.; Aldawod, D.; Dinamarca, M. C.; McNeil, S. Charge-driven lipid nanoparticle encapsulation of enzymes for enhanced ERT with reduced immunogenicity. J. Control. Release 2026, 394, 114859. https://doi.org/10.1016/j.jconrel.2026.114859

Stevens, C. A.; Sevarika, B.; Wilson, B. K.; Wang, C.-M.; Cárcamo-Oyarce, G.; Romeo, J.; Degen, G.; Kassis, T.; Lehr, C.-M.; Carrier, R. L.; Ribbeck, K.; Prud'homme, R. K. Polymer Blend Controls Nanoparticles' Surface Charge for Improved Mucus Penetration and Epithelial Cell Adhesion. Nano Lett. 2025, 25 (49), 16963–16969. https://doi.org/10.1021/acs.nanolett.5c02487

Sevarika, B.; Capri, D.; Frey, J.; Dinamarca, M. C.; Häussinger, D.; McNeil, S. Mannose-6-phosphate-PEG-lipid Conjugates Improve Liposomal Uptake. Eur. J. Pharm. Biopharm. 2025, 209, 114665. https://doi.org/10.1016/j.ejpb.2025.114665

Link to sign up for an Apérohttps://forms.gle/qFJ8pKzQhT5xobaU8
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^

**Please note: this defense below will be held in German**

Who:Florine Marianne Wiss
Research Group:Pharmaceutical Care
Date and time:                29.05.2026, at 14.00 h
Room:                              Alte Universität, Lecture Hall -101, Rheinsprung 9, 4051 Basel
Zoom:        

https://unibas.zoom.us/j/61149201865?pwd=4o1aXgaiTlu5t0iuyUeajWsx0xpgUe.1

Meeting-ID: 611 4920 1865

Kenncode: 852527

Title of the talk:                                      Förderung der Implementierung apothekergeführter PGx-Beratungsdienste in der klinischen Praxis in der Schweiz
List of publications:

2025       Wiss FM, Krieg CD, Lampert ML, et al. CYP2D6 Phenotype as a Predictor of Adverse Drug Reactions in Patients Treated With Trazodone: An Explorative Pharmacogenetic Study. Journal of Clinical Psychopharmacology. Published online March 28, 2022

 

2024      Wiss, F.M., Dietz, U., Thalheimer, A. et al. Associations between (pharmaco-)genetic markers and postoperative pain after inguinal hernia repair – a prospective study protocol. BMC Med Genomics 17, 286 (2024). 

 

2024      Wiss FM, Jakober D, Lampert ML, et al. Overcoming Barriers: Strategies for Implementing Pharmacist-Led Pharmacogenetic Services in Swiss Clinical Practice. Genes (Basel). 2024 Jul 1;15(7):862.

 

2024      Wiss FM, Allemann SS, Meyer Zu Schwabedissen HE, et al. Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction. Front Psychiatry. 2024 Apr 29;15:1397876.

 

2023      Wiss FM, Stäuble CK, Meyer Zu Schwabedissen HE, Allemann SS, Lampert ML. Pharmacogenetic Analysis Enables Optimization of Pain Therapy: A Case Report of Ineffective Oxycodone Therapy. J Pers Med. 2023;13(5):829.

 

If you would like to earn a credit point, please complete the evaluation form and send it to me after each talk. Once you have submitted 10 evaluation forms, you will earn 1 credit point.

Please contact me (phdprogram-dphw@unibas.ch) for the evaluation form. 

 

The evaluation forms won’t be graded or shared with anyone. They are intended to help you reflect on the defense you attend and gain ideas for your own presentation.

 

Nach oben